AbCellera Biologics Inc. ABCL Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from AbCellera Biologics Inc.’s reported figures.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s free cash flow?
- AbCellera Biologics Inc. (ABCL) reported free cash flow of -$37.35M in Q1 2026.
- How has AbCellera Biologics Inc.'s free cash flow changed year-over-year?
- AbCellera Biologics Inc.'s free cash flow decreased by 68.3% year-over-year, from -$22.19M to -$37.35M.
- What is the long-term trend for AbCellera Biologics Inc.'s free cash flow?
- Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s free cash flow has grown at a 20.0% compound annual growth rate (CAGR), from -$120.82M to -$174.07M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.